Catalyst Wire Dossier Catalyst Wire Dossier

Calcium hydroxylapatite dermal filler (two formulations)

calcium hydroxylapatite · Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Calcium hydroxylapatite dermal filler (two formulations), covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler [NA]

See pricing